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Role of cyclooxygenase-2 in H5N1 
viral pathogenesis and the potential 
use of its inhibitors
MY Lee 李敏茵
CY Cheung 張頌恩
JSM Peiris 裴偉士
Key Messages
1. Cyclooxygenase-2 (COX-2), 
along with TNF-α and other 
proinflammatory cytokines, 
was hyperinduced in H5N1-
infected macrophages in 
vitro and in epithelial cells 
of autopsied lung tissues of 
infected patients.
2. The COX-2 mediated 
amplification of the 
proinflammatory response is 
rapid, and the effects elicited 
by the H5N1-triggered 
proinflammatory cascade are 
broader than those arising from 
direct viral infection.
3. Selective COX-2 inhibitors 
suppress the H5N1-
hyperinduced cytokines in the 
proinflammatory cascade.
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Introduction
The highly pathogenic avian influenza viruses (H5N1) in poultry and wild 
birds and their repeated zoonotic transmission to humans has raised concerns 
about pandemics. The severity of H5N1-induced lung pathology may be due 
to increased viral replication and/or inflammatory responses.1 In vitro, infection 
of macrophages and alveolar epithelial cells by H5N1 virus hyperinduces 
proinflammatory cytokines, compared to infection by H1N1 virus.2,3 Deficiency 
of cyclooxygenase-2 (COX-2) in the host response to influenza results in 
less severe disease.4 Moreover, COX-2 is hyperinduced in response to H5N1 
infection, in addition to the proinflammatory cytokine cascade. Therefore, we 
aimed to investigate the role of COX-2 in H5N1 pathogenesis. We hypothesised 
that hyperinduction of COX-2 may play an important role in the pathogenesis of 
H5N1 virus infection.
Methods
This study was conducted from January 2007 to December 2008. The viruses 
used were A/Hong Kong/483/97 (H5N1 virus), a virus isolated from a patient 
with fatal H5N1 disease in Hong Kong in 1997, A/Vietnam/3212/04 (H5N1 
virus), a virus isolated from a patient with H5N1 disease in Vietnam during 2004, 
and A/Hong Kong/54/98 (H1N1 virus).
 Differentiated human macrophages or A549 cells were infected at an MOI=2. 
After 30 minutes of virus absorption, the virus inoculum was removed, and the 
cells were washed and then incubated in the corresponding medium.
 To investigate the paracrine effects of virus-infected macrophages, 
supernatants of H5N1-, H1N1-, and mock-infected macrophages were collected 
at 6 hours post infection. The supernatants were filtered using a 100kDa filter 
(Millipore) to remove any virus and added to fresh (uninfected) macrophages 
or A549 cells. The macrophages or A549 cells were harvested for RNA to study 
COX-2 and cytokine gene expression. 
 To investigate the effects of selective COX-2 inhibitors on cytokine induction 
in macrophages or epithelial cells, the cells were pre-treated for 1 hour with 
nimesulide or NS-398 (Cayman) dissolved in a vehicle consisting of 0.1% 
DMSO prior to virus infection or application of filtered culture supernatant from 
infected macrophages. Cells were incubated in the presence of the selective 
COX-2 inhibitor or drug vehicle (as control) throughout the experiment.
 Gene expression of COX-2 and cytokine was performed using real-time 
PCR. Total RNA was isolated and reverse transcripted. Transcript expression 
was monitored using a Power SYBR Green PCR master mix kit (Applied 
Biosystems) with specific primers. The fluorescence signals were measured in 
real-time during the extension step with MX3000P QPCR System (Stratagene). 
The ratio change in target gene relative to the β-actin control gene was determined 
by the 2-ΔΔCt method.
 The presence of COX-2 in autopsy lung tissues of H5N1-infected patients 
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was detected by specific COX-2 antibody (Cayman) using 
the immunoperoxidase technique. For the co-localisation of 
COX-2 with macrophage and epithelial cell markers, the 
sections were incubated with CD68 (Dako) and AE1/AE3 
(Dako) respectively, followed by incubation with FITC-
conjugated donkey anti-mouse (Jackson Lab). 
Results
As early as 3 hours after infection, COX-2 was markedly up-
regulated in H5N1-infected macrophages (Fig 1a). The less 
virulent H1N1 virus induced COX-2 mRNA with similar 
kinetics as H5N1 virus but at much lower magnitude. As the 
induction of COX-2 in virus-infected cells is abolished by 
pre-treatment of cells with cycloheximide (data not shown), 
its induction is likely to be due to cellular mediators rather 
than direct stimulation by the virus. In contrast to virus-
infected macrophages, COX-2 mRNA was not up-regulated 
in H5N1- or H1N1-infected human alveolar epithelial 
(A549) cells (Fig 1b).
 To determine whether COX-2 was induced in patients 
with H5N1 infection, immunohistochemical study for 
COX-2 protein was performed on autopsy specimens from 
three H5N1-infected patients. In all three specimens, there 
was evidence of cytoplasmic immunostaining for COX-2 in 
the respiratory bronchial epithelial cells and pneumocytes 
(Figs 1c and 1d). The COX-2 expression co-localised with 
cytokeratin antigen demonstrated expression of COX-2 in 
basal cells and ciliated cells of the respiratory epithelium 
(Fig 1e). COX-2 was identified in cytokeratin positive 
alveolar epithelial cells (Fig 1f) but was not co-expressed 
with macrophages as identified by the macrophage marker, 
CD68 (Fig 1g). In contrast, normal lung controls showed 
negative or very weak cytoplasmic staining for COX-2 (Fig 
1h).
 An in vitro model was developed to investigate the 
proinflammatory cascade mimicking the macrophage-
epithelial cell interaction. Culture supernatants of influenza 
A virus–infected human macrophages were collected at 6 
hours after infection, filtered to remove any infectious virus, 
and added to uninfected A549 cells. COX-2 expression was 
markedly up-regulated in epithelial cells challenged with 
supernatant from H5N1-infected macrophages; more so 
than in those challenged with supernatants from H1N1-
infected cells (Fig 2a). Comparable induction of a number 
of cytokines, including TNF-α (Fig 2b to 2g) was also 
observed. 
 Selective COX-2 inhibitor (nimesulide) was used to 
further investigate the role of COX-2 in the proinflammatory 
response induced by H5N1 virus. Expression of all 
tested cytokine mRNAs were significantly suppressed by 
nimesulide at 600 μM in both H5N1- and H1N1-infected 
macrophages (Fig 3a). 
 As the expression of viral M gene was also suppressed 
by nimesulide in a dose-dependent manner (Fig 3b), it is 
uncertain whether the observed reduction in the induction 
of cytokines was partly or wholly due to suppression in 
viral replication. To further investigate the role of COX-
2 within the proinflammatory cascade (distinct from any 
confounding effect of viral replication), virus-filtered 
supernatants from human macrophages infected with 
influenza A virus with or without nimesulide treatment were 
added to uninfected epithelial cells and the consequential 
effect on cytokine expression was determined. Supernatant 
from influenza A virus–infected macrophages which had 
been pre-treated with nimesulide induced lower levels of 
cytokine expression in epithelial cells than did supernatant 
from nimesulide untreated macrophages (Fig 3c). 
Furthermore, treatment of uninfected epithelial cells with 
nimesulide (Fig 3d) led to a suppression of the cytokines 
induced by treating these cells with supernatants from 
influenza A virus–infected macrophages. 
Discussion
In the current study, we demonstrated that effects of the 
proinflammatory cascade was rapid, and the proinflammatory 
mediators induced were more diverse than those induced 
by direct influenza virus infection. Moreover, lethal H5N1 
viruses induced the proinflammatory cascade to levels that 
were much higher than those induced by a seasonal H1N1 
virus. This may explain, to certain extent, why H5N1 virus 
is so pathogenic in humans. Autopsy tissue from patients 
with H5N1 disease showed an extensive induction of 
COX-2 and TNF-α in epithelial cells. As virus antigen was 
scarce in these lung tissues showing COX-2 and TNF-α 
expression, our findings support the hypothesis that the 
cytokine cascade sustains itself even when viral replication 
has been largely controlled.5 As influenza virus infection of 
epithelial cells does not directly trigger COX-2 or TNF-α 
induction, the expression of these proinflammatory genes 
in the lung in the absence of significant viral replication is 
more likely due to a self-sustaining cytokine cascade rather 
than ongoing viral replication, at least in the later stages 
of the illness. Taken together, these findings support the 
hypothesis that excessively induced host inflammatory 
responses play a major role in contributing to the severity 
of human H5N1 disease.
 Selective COX-2 inhibitors were able to attenuate 
the expression of a number of influenza A virus induced 
proinflammatory cytokines. Nimesulide was able to 
decrease the transcription of viral M gene, suggesting 
that nimesulide may also suppress viral replication. 
As the decrease in cytokine induction could be at least 
in part attributed to decrease in viral replication, to 
further demonstrate that COX-2 was indeed involved in 
mediating the induction of proinflammatory cytokines, 
we designed experiments to show that nimesulide reduced 
the induction of proinflammatory cytokines elicited by 
soluble factors derived from H5N1-infected macrophages. 
These experiments avoided the confounding effect of viral 
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Fig 1. (a) In macrophages, cyclooxygenase-2 (COX-2) is markedly up-regulated by an H5N1 virus within 3 hours and further 
increased by 6 hours. An H1N1 virus induces a much weaker response. (b) In A549 epithelial cells, there is no induction of COX-2 
by either virus. Data shown are fold change of COX-2 expression relative to mock-infected control after normalising to beta-actin 
in each sample. Representative data of duplicate experiments with means of triplicate assays are shown. COX-2 is expressed 
extensively in the lung epithelial cells of persons who died of H5N1 infection. Immunohistochemistry for COX-2 protein in H5N1-
infected lungs shows strong cytoplasmic staining in (c) bronchial epithelial cells and (d) pneumocytes. (e) Double staining for 
COX-2 (DAB brown) and cytokeratin antigen (FITC green) in fatal H5N1 pneumonia demonstrates cytoplasmic staining of basal 
cells and ciliated cells (white arrows). COX-2 is expressed in (f) cytokeratin-positive alveolar epithelial cells (white arrows) but 
not in (g) macrophages as identified by the CD68 macrophage marker (FITC green) [white arrows]. (h) Representative data of two 
lung tissues from persons who died of non-respiratory causes show little or no staining for COX-2. Scale bar of double-stained 
images is 200 µm.
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Fig 2. (a) Cyclooxygenase-2 (COX-2) expression is markedly up-regulated by the supernatants collected from H5N1-infected 
macrophages, peaking at 3 hours post-challenge. Supernatants collected from H1N1-infected macrophages cause only a small 
rise in COX-2 expression. Comparable findings are observed for other cytokines: (b) TNF-α, (c) CCL-2/MCP-1, (d) CXCL-10/
IP-10, (e) IL-1b, (f) IL-6, and (g) TRAIL. Data shown are fold change of gene expression relative to mock-infected control after 
normalising to beta-actin in each sample. Representative data of duplicate experiments with means of triplicate assays are 
shown.
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Fig 3. (a) A panel of cytokines tested show attenuation in expression level at 600 µM nimesulide after influenza A infection 
in macrophages. (b) Viral M gene transcription in influenza A–infected macrophages is attenuated by nimesulide in a dose-
dependent manner. Cytokine expression is attenuated within the proinflammatory cascade by nimesulide. (c) Cytokine 
expression is attenuated in epithelial cells challenged with supernatants from influenza A–infected macrophages, which have 
been treated with 200 µM nimesulide. (d) Treating epithelial cells with 200 µM nimesulide show similar attenuation in cytokine 
expression induced by supernatants from influenza A–infected macrophages. Data shown are fold change of gene expression 
relative to corresponding mock after normalising to beta-actin in each sample. Representative data of duplicate experiments 
with means of triplicate assays are shown.
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infection, as the macrophage supernatants were filtered to 
remove the virus. The current paradigm is that COX-2 is 
induced by cytokines.5 We demonstrated that COX-2 drove 
and maintained the proinflammatory cascade via a complex 
positive feedback loop during H5N1 infection.
 At present, early antiviral therapy by oseltamivir is 
the mainstay for managing patients with H5N1 disease. 
However, the clinical response to antiviral therapy has 
been variable. This can be attributed to a number of factors, 
including delayed commencement of therapy, development 
of antiviral resistance, and poor bio-availability of the 
oral drug in severely ill patients. The cytokine cascade 
was maintained even in the absence of significant virus 
infection in the lung. Thus, in addition to antiviral 
therapy, interventions to selectively modulate this cascade 
may be helpful. One such potential intervention is the 
inhibition of the COX-2 pathway, which may attenuate 
the proinflammatory cascade and possibly the pathology 
associated with it. Such an approach may be more beneficial 
than attenuating the action of a single cytokine such as 
TNF-α using direct antagonists. COX-2 inhibitors are 
either already registered for clinical use or undergoing late 
phase clinical trials, and may also have the added benefit of 
inhibiting viral replication.
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